AstraZeneca PLC is 302.9x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $945.18 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRVS | AZN |
|---|---|---|
| Market cap | $945.18 M | $286.27 B |
| US-listed rank | #2651 | #45 |
| Net income (latest FY) | -$15.30M | - |
| SEC filings | 570 | 1,004 |
AstraZeneca PLC is 302.9x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $945.18 M).
Full pages: Corvus Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.